Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Beta Bionics is raising $63,360,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Ed Damiano played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Beta Bionics

Beta Bionics is proud to be a Massachusetts public benefit corporation. We believe we are one of the first, if not the first medical device company to be doing business as a benefit corporation, and we’re fairly certain that Beta Bionics is the first company to do so in the diabetes space. We believe our status as a public benefit corporation is going to make all the difference in the way we do business and, ultimately, will result in a healthier and happier T1D community.

To learn more about Beta Bionics, visit http://www.betabionics.org/

Contact:
Ed Damiano, Cheif Executive Officer
909-800-3351
edamiano@betabionics.org

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved